Intrapartum Glycemic Control in GDMA2

This is a randomized, parallel, controlled, non-inferiority trial to assess the impact of a tight versus a more liberalized intrapartum glycemic control in gestational diabetic mothers on neonatal glycemia. National guidelines for the management of intrapartum glucose in women with GDM are lacking. This is likely due to the scarcity of high-quality data on the topic.

Inclusion Criteria:Women 18 years or olderNon-anomalous singleton gestationGestational diabetes type A2 diagnosed at 24 weeks' gestation or beyondPlanned vaginal delivery at term at Inova Fairfax Women's HospitalExclusion Criteria:Women < 18 yearsFetus with major congenital malformationsTwin or higher order gestationPre-existing diabetes mellitusExposure to antenatal or any systemic steroids 14 days or less prior to deliveryPreterm deliveryScheduled cesarean birthIntrapartum cesarean birth prior to 4-5 cm of cervical dilatation